Skip to content

Author

Busayo Olamide Tomoh

We have 1 of 31 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Nanocarriers for Targeted Drug Delivery in Cancer Therapy: Innovations and Challenges

In conclusion, while nanocarriers offer significant advancements in targeted cancer therapy, their successful clinical implementation depends on overcoming various scientific, technical, and regulatory challenges.

Busayo Olamide Tomoh · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.